Patient response and resource management: another view of clozapine treatment of schizophrenia.
about
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapineNovelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area.A comparative review of new antipsychotics.Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009.Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic.Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studiesPharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?The prescribing practices of olanzapine in a psychiatric hospital in Britain.Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus.New antipsychotic medications: what advantages do they offer?New dimensions in the pharmacologic treatment of schizophrenia and related psychoses.Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.An open clinical trial with clozapine in treatment-resistant schizophrenics.Emerging role of sertindole in the management of schizophrenia.Novel antipsychotics and the neuropsychological deficiencies of schizophrenia.Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009.The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.Risperidone plasma levels, clinical response and side-effects.Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies.Clinical correlates of clozapine prescription for schizophrenia in China.Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study.CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia
P2860
Q28280783-2DA1D93E-661D-4DBA-9FA0-69C02E7CABD3Q32027963-DA0ACE67-69CA-4D65-978D-7979240578FAQ33606079-2CEDCBC5-9724-4135-BD1B-9E54826B69D6Q33726559-3E076182-0ACE-43B9-8729-7D0AE7104047Q34338202-45051F93-BFC9-414B-875E-FDA772E64148Q34770565-39C22652-B064-4A28-AC8F-B44DFAEA2441Q36179715-53C517C0-907F-439D-B0F9-4B9B865F1197Q36600791-831B5E58-22CC-4778-A21A-5A891C1BB042Q36715888-F674A194-8F41-4EDA-A72B-37C72F62AB0FQ38221178-5E42F04B-AA25-4FC0-BAA2-FA37847A22B7Q38340649-10D31BC0-752C-4262-B110-277E96069B34Q41360368-2E9E8DCF-E5F8-40A9-A4FD-E28971BAD93CQ41475059-B935B7EF-7A6A-4A2D-882A-629717B80B77Q41656936-E59312E0-A591-4A96-B31A-1A5CF07BC3FEQ41874579-B9DA4A08-0E67-4375-A133-C879EEDA0774Q42427678-F1F5EB7D-D72F-44E5-A3D0-24FC398796B3Q43246257-06385AA1-2F4F-4F30-8137-9188AD48101DQ43511566-8FBFD5EF-9792-4904-B96D-BD93C0F8FFD2Q44048476-542D7FE7-3B37-43C9-88ED-0FE6578F3204Q45163701-5F7E2C82-C2F9-42C1-9B34-0DA9DA9B55E3Q45732990-E7E5275F-0A0F-401B-8649-97AFE89F937AQ47822171-4052CE22-9297-4B47-B7DF-419BAFDAE3CEQ48102746-4E51446C-D4FC-47A0-A8DB-1522890968F9Q57820328-0CD14486-02B1-4C77-A712-05E97BE9C60D
P2860
Patient response and resource management: another view of clozapine treatment of schizophrenia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Patient response and resource ...... ne treatment of schizophrenia.
@en
type
label
Patient response and resource ...... ne treatment of schizophrenia.
@en
prefLabel
Patient response and resource ...... ne treatment of schizophrenia.
@en
P2093
P356
P1476
Patient response and resource ...... ne treatment of schizophrenia.
@en
P2093
Buchanan RW
Carpenter WT Jr
Tamminga CA
P304
P356
10.1176/AJP.152.6.827
P407
P577
1995-06-01T00:00:00Z